Inflammatory Lung Disease
1 clinical trials · Condition
◉ Watch Inflammatory Lung Disease
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications (NCT05104723) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-08-12 |
Track Inflammatory Lung Disease automatically
Every clearance here is in the API, with alerts when new ones post.